The George Institute For Global Health
Global
United Kingdom
India
China
Australia

Home

2017
Duane F, Aznar MC, Bartlett F, et al. A cardiac contouring atlas for radiotherapy. Radiother Oncol. 2017;122(3):416-422. doi:10.1016/j.radonc.2017.01.008.
Rahimi K, Mohseni H. Patients with coronary heart disease and very low blood pressure are at increased risk of cardiovascular events. Evid Based Med. 2017;22(2):73. doi:10.1136/ebmed-2016-110648.
Rahimi K. Subclinical atrial fibrillation in need of more assertive evidence. Eur Heart J. 2017. doi:10.1093/eurheartj/ehx122.
2016
Emdin CA, Rothwell PM, Salimi-Khorshidi G, et al. Blood Pressure and Risk of Vascular Dementia: Evidence From a Primary Care Registry and a Cohort Study of Transient Ischemic Attack and Stroke. Stroke. 2016;47(6):1429-35. doi:10.1161/STROKEAHA.116.012658.
Emdin CA, Rothwell PM, Salimi-Khorshidi G, et al. Blood Pressure and Risk of Vascular Dementia: Evidence From a Primary Care Registry and a Cohort Study of Transient Ischemic Attack and Stroke. Stroke. 2016;47:1429-35.
Ettehad D, Emdin CA, Kiran A, Rahimi K. Blood pressure lowering for cardiovascular disease - Authors' reply. Lancet. 2016;388:126-7.
Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387:957-67.
Chantler T, Paton C, Velardo C, et al. Creating connections – the development of a mobile-health monitoring system for heart failure: Qualitative findings from a usability cohort study. Digital Health. 2016;2.
Wang H, Wolock TM, Carter A, et al. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIVLancet HIVLancet HIV. 2016;3:e361-87.
Collaborators GBD2015 DALYs, Jha V, Rahimi K. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1603-1658.
Collaborators GBD2015 Disea, Rahimi K. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1545-1602.
Collaborators GBD2015 Mater, Jha V, Rahimi K. Global, regional, and national levels of maternal mortality, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1775-1812.
Collaborators GBD2015 Morta, Jha V, Rahimi K. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459-1544.
Kiran A, Crespillo AP, Rahimi K. Graphical displays for meta-analysis. Heart. 2016.
Mokdad AH, Forouzanfar MH, Daoud F, et al. Health in times of uncertainty in the eastern Mediterranean region, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet Glob Health. 2016.
Rahimi K, Otto CM. Heartbeat: Is atrial fibrillation ablation effective in patients with hypertrophic cardiomyopathy?. Heart. 2016;102:1511-2.
Otto CM, Rahimi K. Heartbeat: The gut microbiota and heart failure. Heart. 2016;102:811-2.
Rahimi K. Influenza vaccination and risk of hospitalisation in patients with heart failure: a report from the UK primary and secondary care records [invited speaker]. In: Heart Failure Congress. Heart Failure Congress. Florence, Italy; 2016.
Mohseni H, Kiran A, Khorshidi R, Rahimi K. Influenza vaccination and risk of hospitalization in patients with heart failure: a self-controlled case series study. European Heart Journal. 2016.
Haynes R, Rahimi K. Niacin: old habits die hard. Heart. 2016;102:170-1.
Kiran A, Conrad N, Rahimi K. Nonlinear Exposure-Outcome Associations and Public Health Policy. Journal of the American Medical Association. 2016;315:1287-8.
Anderson SG, Hutchings DC, Woodward M, et al. Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality. Heart. 2016;102:1750-1756.
Rahimi K. The long and unfinished journey of hyperglycaemia and heart failure research. Heart. 2016.
Emdin CA, Anderson SG, Salimi-Khorshidi G, et al. Usual blood pressure, atrial fibrillation and vascular risk: evidence from 4.3 million adults. International Journal of Epidemiology. 2016.
Emdin CA, Conrad N, Kiran A, et al. Variation in hospital performance for heart failure management in the National Heart Failure Audit for England and Wales. Heart. 2016.

Pages